• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮素-1受体拮抗剂BQ-123对大鼠蛛网膜下腔出血(SAH)后基底动脉直径的影响。

Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats.

作者信息

Jośko J, Hendryk S, Jedrzejowska-Szypułka H, Słowiński J, Gwóźdź B, Lange D, Harabin-Słowińska M

机构信息

Department of Physiology Silesian University School of Medicine, Zabrze, Poland.

出版信息

J Physiol Pharmacol. 2000 Jun;51(2):241-9.

PMID:10898097
Abstract

Aim of the study was to quantify cerebral vasospasm in rats after subarachnoid hemorrhage (SAH) by morphometric examination of basilar artery and to evaluate the influence of endothelin receptor blocker BQ-123 on basilar artery constriction. The rat cisterna magna (CM) was cannulated and after 7 days SAH was developed by administration of 100 microl autologic, non-heparinized blood to the CM. The sham subarachnoid hemorrhage was developed by intracisternal administration of 100 microl of artificial cerebrospinal fluid. Endothelin receptor blocker BQ-123 was injected into the CM in a dose of 40 nmol diluted in 50 microl of cerebrospinal fluid 20 min. before SAH, and 24h and 48 h after SAH. After perfusion fixation the brains were removed from the skull and histological preparations of basilar artery were done. The internal diameter and wall thickness of basilar arteries was measured by interactive morphometric method. The most severe vasospasm was found in rats after SAH. The presence of numerous infiltrations composed of neutrophils and macrophages correlated with advanced vasospasm (index of constriction 5 times lower than in normal), suggesting the role of other factors participating in the late phase of vasospasms after SAH. Administration of BQ-123 in the late phase after SAH caused the dilatation of basilar artery. Following the administration of BQ-123 in the late phase (48 h after SAH) the basilar artery dilated, its wall became thinner, and the number of leukocyte infiltrations in the subarachnoid space decreased compared to the values after SAH alone.

摘要

本研究的目的是通过对基底动脉进行形态计量学检查来量化大鼠蛛网膜下腔出血(SAH)后的脑血管痉挛,并评估内皮素受体阻滞剂BQ-123对基底动脉收缩的影响。将大鼠枕大池(CM)插管,7天后通过向CM内注入100微升自体、非肝素化血液诱导SAH。通过向脑池内注入100微升人工脑脊液诱导假蛛网膜下腔出血。在SAH前20分钟、SAH后24小时和48小时,将内皮素受体阻滞剂BQ-123以40纳摩尔的剂量稀释于50微升脑脊液中注入CM。灌注固定后,将大脑从颅骨中取出并制作基底动脉的组织学标本。通过交互式形态计量学方法测量基底动脉的内径和壁厚。在SAH后的大鼠中发现了最严重的血管痉挛。由中性粒细胞和巨噬细胞组成的大量浸润的存在与严重的血管痉挛相关(收缩指数比正常情况低5倍),提示其他因素在SAH后血管痉挛后期发挥作用。在SAH后期给予BQ-123可导致基底动脉扩张。在SAH后期(SAH后48小时)给予BQ-123后,基底动脉扩张,其壁变薄,蛛网膜下腔白细胞浸润数量比单纯SAH后减少。

相似文献

1
Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats.内皮素-1受体拮抗剂BQ-123对大鼠蛛网膜下腔出血(SAH)后基底动脉直径的影响。
J Physiol Pharmacol. 2000 Jun;51(2):241-9.
2
Reactivity of cerebral arteries after subarachnoid hemorrhage in rats after phosphoramidon administered.
Med Sci Monit. 2000 Sep-Oct;6(5):976-80.
3
Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats.大鼠蛛网膜下腔出血(SAH)后的脑内血管生成以及用BQ-123拮抗剂阻断内皮素受体的情况
J Physiol Pharmacol. 2001 Jun;52(2):237-48.
4
The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.内皮素拮抗剂BQ-610对实验性蛛网膜下腔出血和脑血管痉挛后脑血管壁的影响。
Clin Auton Res. 2004 Jun;14(3):197-201. doi: 10.1007/s10286-004-0190-2.
5
Influence endothelin ETA receptor antagonist--BQ-123--on changes of endothelin-1 level in plasma of rats with acute vasospasm following subarachnoid hemorrhage.内皮素ETA受体拮抗剂——BQ-123——对蛛网膜下腔出血后急性血管痉挛大鼠血浆内皮素-1水平变化的影响。
J Physiol Pharmacol. 1998 Sep;49(3):367-75.
6
Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.内皮素-A受体拮抗剂TBC 11251的全身给药可减轻实验性蛛网膜下腔出血后的脑血管痉挛:剂量研究及关于脑血管痉挛的文献中基于内皮素的治疗方法综述
Neurosurgery. 1998 Dec;43(6):1409-17; discussion 1417-8.
7
BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection.BQ-123是一种肽类内皮素ETA受体拮抗剂,脑池内注射而非静脉注射时,它可预防蛛网膜下腔出血后的早期脑血管痉挛。
Life Sci. 1993;52(9):825-34. doi: 10.1016/0024-3205(93)90081-d.
8
Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.腺病毒介导的一氧化氮合酶基因转移对实验性蛛网膜下腔出血后血管痉挛的影响。
Neurosurgery. 2000 May;46(5):1193-202; discussion 1202-3. doi: 10.1097/00006123-200005000-00034.
9
Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.氧化型低密度脂蛋白及凝集素样氧化型低密度脂蛋白受体-1在蛛网膜下腔出血后脑血管痉挛中的作用
J Neurosurg. 2014 Sep;121(3):621-30. doi: 10.3171/2014.5.JNS132140. Epub 2014 Jun 20.
10
Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm.内皮素B受体拮抗剂可减轻蛛网膜下腔出血所致的脑血管痉挛。
Stroke. 1998 Sep;29(9):1924-9. doi: 10.1161/01.str.29.9.1924.

引用本文的文献

1
The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies.沙坦类药物在中风和蛛网膜下腔出血治疗中的作用:临床前和临床研究的叙述性综述
Brain Sci. 2020 Mar 7;10(3):153. doi: 10.3390/brainsci10030153.
2
Effect of endothelin receptor antagonists on clinically relevant outcomes after experimental subarachnoid hemorrhage: a systematic review and meta-analysis.内皮素受体拮抗剂对实验性蛛网膜下腔出血后临床相关结局的影响:一项系统评价和荟萃分析。
J Cereb Blood Flow Metab. 2015 Jul;35(7):1085-9. doi: 10.1038/jcbfm.2015.89. Epub 2015 May 6.
3
Pharmacologic reduction of angiographic vasospasm in experimental subarachnoid hemorrhage: systematic review and meta-analysis.
实验性蛛网膜下腔出血中血管痉挛的药物治疗:系统评价和荟萃分析。
J Cereb Blood Flow Metab. 2012 Sep;32(9):1645-58. doi: 10.1038/jcbfm.2012.57. Epub 2012 Apr 25.